Thermo Fisher Scientific, Inc. (TMO)
|Net Income (ttm)||6.38B|
|Trading Day||May 7|
|Day's Range||467.90 - 478.99|
|52-Week Range||323.63 - 532.02|
Shares of Thermo Fisher Scientific (NYSE:TMO) fell 1.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 145.24% over the past year to $7.21, w...
Here's what to look for and what to steer clear of.
WALTHAM, Mass., April 29, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 3, 2...
Final Trades: Thermo Fisher, Kinder Morgan, EQT Corp. & more
The "Halftime Report" traders give their top picks to watch for the second half.
Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate...
Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Final Trades: XPO Logistics, Thermo Fisher, Bunge & more
The "Halftime Report" traders give their top picks to watch for the second half.
Fewer hospital visits on growing new cases might have once again impacted the level of routine diagnostics testing activity for Thermo Fisher (TMO) in Q1.
Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
PPD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price...
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of PPD, Inc. (NasdaqG...
Thermo Fisher's (TMO) $17.4-billion acquisition deal will offer the company meaningful cost and revenue synergies.
Thermo Fisher Scientific (TMO) has agreed to buy the healthcare testing company PPD Inc. (PPD) for $17.4 billion in cash.
Thermo Fisher Scientific is buying clinical research organization PPD in a $17.4 billion cash-and-debt deal, the companies said Thursday. Both TMO stock and PPD stock popped on the news.
WALTHAM, Mass. and WILMINGTON, N.C.
Thermo Fisher nears deal to buy PPD for more than $15B
Thermo Fisher is nearing a deal to buy PPD for more than $15 billion dollars, according to The Wall Street Journal. Contessa Brewer joins 'Closing Bell' to report.
Thermo Fisher's (TMO) Amplitude Solution is likely to allow clinical and public health laboratories to process up to 8,000 samples in a single day with the help of minimum workforce.
In diagnostics and healthcare, Thermo Fisher (TMO) is experiencing high demand for COVID-19 testing and manages to record 200% growth.
WALTHAM, Mass., April 12, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has granted...
Thermo Fisher Scientific (NYSE:TMO) is a well-known name in the pharmaceutical and biotech industries that has witnessed remarkable growth in 2020, leveraging on its capacity to extend support amidst th...
Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
WALTHAM, Mass., April 5, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2...
Investment company First National Bank of Mount Dora, Trust Investmen (Current Portfolio) buys Thermo Fisher Scientific Inc, VMware Inc, Fiserv Inc, Equinix Inc, Honeywell International Inc, sells Eastm...
The latest launch of surveillance solution is an extremely timely development by Thermo Fisher (TMO) and is expected to witness fast market adoption.
Yesterday was a rough day for risk assets after Germany announced an Easter lockdown to avoid a new acceleration in Covid-19 cases and deaths. The measures are a response to recent worrying signs of tro...
WALTHAM, Mass., March 24, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the launch of the Thermo Scientific AerosolSense Sampler, a ...
With the trading day about halfway over, the broad markets were mixed. The Nasdaq took something of a beating, with a loss of over 1% on the day.
These steady, strong healthcare stocks are great picks for investors to buy and hold onto for at least the next five years. The post 7 Healthcare Stocks to Buy and Hold for the Long Term appeared first ...
WALTHAM, Mass., March 10, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced more than $600 million in capital investments to expand its ...
Thermo Fisher Scientific (TMO) closed at $446.87 in the latest trading session, marking a +1.23% move from the prior day.
Both of these giant stocks have outperformed the market over the past year by a mile.
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
Despite already rising 1.8x from its low in March 2020, at the current price of $460 per share, we believe Thermo Fisher Scientific stock has further upside potential. TMO stock has increased from $255 ...
Mesa Biotech's point-of-care platform is likely to help Thermo Fisher (TMO) rapidly scale up manufacturing volume amid the pandemic.
The battle against Covid-19 is about to get uglier. Coronavirus mutations threaten to undercut a year's worth of work upholding Covid stocks like Pfizer, Moderna and Regeneron Pharmaceuticals.
Customers in Thermo Fisher's (TMO) industrial and applied end markets get affected by business disruptions due to the pandemic.
WALTHAM, Mass., Feb. 24, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive offic...
WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector
SHANGHAI, Feb. 23, 2021 /PRNewswire/ -- WuXi Diagnostic Investment (Cayman) Limited ("WuXi Diagnostics") announced that it has completed US$150 million in series B funding, joined by new investors inclu...
WALTHAM, Mass., Feb. 23, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash ...
WALTHAM, Mass., Feb. 18, 2021 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced it has won six awards in the annual CMO Leadership Awards. The awards, presen...
Thermo Fisher Scientific Launches CE-IVD-Marked High Throughput COVID-19 Diagnostic Assay for Use On Its Automated Am...
CARLSBAD, Calif., Feb. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today launched its CE-IVD-Marked, Applied Biosystems TaqPath COVID–19 HT Kit that is compati...
Rockwell Automation CEO on Thermo Fisher Scientific, Kraft Heinz partnerships
Rockwell Automation CEO Blake Moret broke down the industrial automation and information technology company's relationships with Thermo Fisher Scientific and Kraft Heinz.
WALTHAM, Mass., Feb. 3, 2021 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, has signed an agreement with JW Therapeutics, a leading cell therapy company, to ensure non-ex...
Thermo Fisher CEO: Covid vaccines, therapies will be needed well into the future
Thermo Fisher Scientific CEO Marc Casper explained his outlook for the necessity of coronavirus vaccines and therapies as the country continues to battle the pandemic.
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consuma... [Read more...]
Diagnostics & Research
|Stock Exchange |
|Ticker Symbol |
In 2020, TMO's revenue was $32.22 billion, an increase of 26.14% compared to the previous year's $25.54 billion. Earnings were $6.38 billion, an increase of 72.48%.
According to 22 analysts, the average rating for TMO stock is "Buy." The 12-month stock price forecast is 560.31, which is an increase of 19.61% from the latest price.